With the growing research interest in cancer immunotherapy, many new checkpoints have been identified and extensively studied in recent years, such as TIM3, TIGIT, VISTA, LAG-3, BTLA, B7-H3, B7-H4, and B7-H5 (15–19). This evidence concerns the gene TIGIT and cancer.